| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 16, 2005
Accepted on September 22, 2005
Section of Epidemiology, Institute of Cancer Research (AJS, CDH, MJS), Sutton, Surrey SM2 5NG; Cell & Molecular Genetics Section, MRC Human Genetics Unit, Western General Hospital (AFW), Edinburgh; Wessex Regional Genetics Laboratory, Salisbury District Hospital (PAJ), Salisbury, Wilts, UK
* To whom correspondence should be addressed. E-mail: anthony.swerdlow{at}icr.ac.uk.
Context: Klinefelter syndrome is characterized by hypogonadism and infertility, consequent on the presence of extra X chromosome(s). There is limited information about long-term mortality in this syndrome because there have been no large cohort studies.
Objectives: To investigate mortality in men with Klinefelter syndrome.
Design & Setting: We obtained data about patients diagnosed with Klinefelter syndrome at almost all cytogenetics centers in Britain, as far back as records were available, and conducted a cohort study of their mortality, overall and by karyotype.
Patients: 3518 patients diagnosed since 1959, followed to mid-2003.
Outcome measure: Standardized mortality ratio (SMR).
Results: 461 deaths occurred. There was significantly raised mortality overall (SMR, 1.5; 95% confidence interval (CI), 1.4 - 1.7) and from most major causes of death including cardiovascular disease (SMR, 1.3; 95% CI, 1.1 - 1.5), nervous system disease (SMR, 2.8; 95% CI, 1.6 - 4.6) and respiratory disease (SMR, 2.3; 95% CI, 1.8 - 2.9). Mortality was particularly raised from diabetes (SMR, 5.8; 95% CI, 3.4 - 9.3), epilepsy (SMR, 7.2; 95% CI, 3.1 - 14.1), pulmonary embolism (SMR, 5.7; 95% CI, 2.5 - 11.3), peripheral vascular disease (SMR, 7.9; 95% CI, 2.9 - 17.2), vascular insufficiency of the intestine (SMR, 12.3; 95% CI, 4.0 - 28.8), renal disease (SMR, 5.0; 95% CI, 2.0 - 10.3), and femoral fracture (SMR, 39.4; 95% CI, 4.8 - 142.3). Mortality from ischemic heart disease was significantly decreased (SMR, 0.7; 95% CI, 0.5 - 0.9).
Conclusions: Patients diagnosed with Klinefelter syndrome have raised mortality from several specific causes. This may reflect hormonal and genetic mechanisms.
This article has been cited by other articles:
![]() |
M. Grossmann, M. C. Thomas, S. Panagiotopoulos, K. Sharpe, R. J. MacIsaac, S. Clarke, J. D. Zajac, and G. Jerums Low Testosterone Levels Are Common and Associated with Insulin Resistance in Men with Diabetes J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1834 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Handelsman Update in Andrology J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4505 - 4511. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Araujo, V. Kupelian, S. T. Page, D. J. Handelsman, W. J. Bremner, and J. B. McKinlay Sex Steroids and All-Cause and Cause-Specific Mortality in Men Arch Intern Med, June 25, 2007; 167(12): 1252 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Selvin, M. Feinleib, L. Zhang, S. Rohrmann, N. Rifai, W. G. Nelson, A. Dobs, S. Basaria, S. H. Golden, and E. A. Platz Androgens and Diabetes in Men: Results from the Third National Health and Nutrition Examination Survey (NHANES III) Diabetes Care, February 1, 2007; 30(2): 234 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stochholm, S. Juul, K. Juel, R. W. Naeraa, and C. Hojbjerg Gravholt Prevalence, Incidence, Diagnostic Delay, and Mortality in Turner Syndrome J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3897 - 3902. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bojesen, K. Kristensen, N. H. Birkebaek, J. Fedder, L. Mosekilde, P. Bennett, P. Laurberg, J. Frystyk, A. Flyvbjerg, J. S. Christiansen, et al. The Metabolic Syndrome Is Frequent in Klinefelter's Syndrome and Is Associated With Abdominal Obesity and Hypogonadism Diabetes Care, July 1, 2006; 29(7): 1591 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Handelsman and P. Y. Liu Klinefelter's Syndrome--A Microcosm of Male Reproductive Health. J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1220 - 1222. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |